From October 1, 2015 to December 31, 2015, the company has repurchased 3,045,600 shares, representing 0.29% for $252.91 million. With this, the company has completed the repurchase of 32,384,700 shares, representing 3.02% for $2,048.91 million under the buyback announced on October 3, 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
941.6 USD | -0.93% | +0.98% | +61.53% |
02:35pm | Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793 | MT |
09:00am | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.53% | 86TCr | |
+38.95% | 63TCr | |
-3.66% | 36TCr | |
+15.06% | 32TCr | |
+9.18% | 30TCr | |
+5.89% | 23TCr | |
+16.53% | 23TCr | |
+15.67% | 18TCr | |
+2.47% | 16TCr | |
+2.41% | 13TCr |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Tranche Update on Eli Lilly and Company's Equity Buyback Plan announced on October 3, 2013.